Imodiumduo

Loperamide Hydrochloride and Dimeticone, the active ingredient in Imodiumduo, is an antidiarrheal (opioid receptor agonist) and anti‑foaming agent presented as an oral tablet for oral use. It is indicated for relief of acute diarrhea, travelers' diarrhea, and symptoms of gas and bloating in adults and children when appropriate. GNH USA supplies Imodiumduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodiumduo acts on the gastrointestinal tract to reduce excessive bowel movements and alleviate gas-related discomfort. - Acute diarrhea: decreases stool frequency and improves stool consistency. - Travelers' diarrhea: provides rapid symptom control for travelers experiencing sudden onset diarrhea. - Gas and bloating: dimeticone reduces surface tension of gas bubbles, facilitating their elimination and relieving abdominal distension.

Imodiumduo may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: reduced bowel movements leading to hard stools. - Nausea: feeling of queasiness or urge to vomit. - Abdominal cramps: mild to moderate stomach discomfort. - Dry mouth: reduced salivation causing throat dryness. - Dizziness: light‑headed sensation, especially when standing quickly.

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction: persistent blockage requiring medical attention. - Ileus: paralytic bowel condition with absent peristalsis. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heart rhythm in susceptible individuals. - Central nervous system effects: drowsiness or confusion at high systemic levels.

Before using Imodiumduo, consider the following safety measures. - Do not exceed recommended dose: follow prescriber or label instructions to avoid toxicity. - Use caution in hepatic impairment: reduced metabolism may increase drug exposure. - Avoid in children under 2 years: risk of severe constipation and dehydration. - Seek medical advice if diarrhea persists >48 hours: may indicate infection requiring treatment. - Monitor for dehydration: ensure adequate fluid intake during illness. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Imodiumduo can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid): - Other antidiarrheal agents: additive slowing of gut motility may cause obstruction. - Strong CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): increase loperamide plasma levels, raising risk of cardiac events. - Opioid analgesics: synergistic opioid effects may lead to excessive sedation or respiratory depression. - Anticholinergic drugs: heightened risk of severe constipation. - MAO inhibitors: potential for enhanced serotonergic activity.

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption of loperamide, affecting efficacy. - Rifampin: enzyme induction can reduce loperamide concentrations, diminishing effect. - Diuretics: increased risk of dehydration when combined with fluid loss from diarrhea.